drugset
drugset / Trial / NCT02891148

Single Rising Dose Study of BI 690517 in Healthy Volunteers

NCT02891148 ↗

Phase 1 Completed 50 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

To investigate safety, tolerability, pharmacokinetics and pharmacodynamics following single rising doses of BI 690517

Timeline

Start
2016-09-29
Primary completion
2016-12-12
Completion
2016-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Vicadrostat Small molecule — —

Indications

No indication recorded.